Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Ephrin-A4 Ligand Promotes Gastric Cancer Cell Epithelial-Mesenchymal Transition Via The PI3K/AKT Signaling Pathway

ABSTRACT: Background Ephrin A4 (EFNA4), a member of the ephrin ligand family, is implicated in the progression of multiple malignant tumors. However, its functional role in gastric cancer (GC) remains poorly understood. Thus, this study was designed to investigate the potential mechanisms through which EFNA4 operates in GC. Methods and results Firstly, bioinformatic assessments indicated significantly elevated levels of EFNA4 in GC tissues compared to normal tissues. Secondly, Clinical data from a cohort of 93 GC patients further demonstrated associations between EFNA4 expression and differentiation, tumor size, as well as TNM stage. Furthermore, high EFNA4 expression was correlated with reduced overall survival, indicating its prognostic significance. Thirdly, In vitro experiments revealed that silencing EFNA4 suppressed the proliferation, invasion, and migratory capacity of GC cells. Additionally, knockdown of EFNA4 inhibited epithelial-mesenchymal transition (EMT) by modulating the PI3K/AKT signaling cascade. Treatment with 740Y-P, a PI3K activator, enhanced the expression of PI3K/AKT-related proteins but did not affect the expression of EFNA4. Conclusions These findings indicate that EFNA4 may act as an upstream regulator within the PI3K/AKT signaling axis, playing a key regulatory role in the EMT process during GC progression.

ORGANISM(S): Homo sapiens

PROVIDER: GSE297687 | GEO | 2026/05/05

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Ephrin-A4 Ligand Promotes Gastric Cancer Cell Epithelial-Mesenchymal Transition Via The PI3K/AKT Signaling Pathway

Project description:Ephrin-A4 Ligand Promotes Gastric Cancer Cell Epithelial-Mesenchymal Transition Via The PI3K/AKT Signaling Pathway

| PRJNA1265693 | ENA

Project description:Identification of germinal center (GC) B cells is typically reliant on the use of surface activation markers that exhibit a wide range of expression. Here we identify Ephrin-B1, a ligand for Eph-related receptor tyrosine kinases, as a specific marker of mature GC B cells. The number of Ephrin-B1+ GC B cells increases during the course of an immune response with Ephrin-B1+ GC B cells displaying elevated levels of Bcl6, S1pr2, and Aicda relative to their Ephrin-B1– counterparts. We further identified a small proportion of recently dividing, somatically mutated Ephrin-B1+ GC B cells that have begun to downregulate Bcl6 and S1pr2 and express markers associated with memory B cells such as CD38 and EBI2. Transcriptional analysis indicates that these cells are developmentally related to memory B cells, and likely represent a population of GC memory precursor (PreMem) B cells. GC PreMem cells display enhanced survival relative to bulk GC B cells, localize near the edge of the GC and are predominantly found within the light zone. These findings offer insight into the significant heterogeneity that exists within the GC B cell population and provide tools to further dissect signals regulating the differentiation of GC B cells.

2017-01-26 | GSE89897 | GEO

ENO1 influences ATP pool of cytoplasm and lactate homeostasis by regulating glycolysis to promote tumor stemness and metastasis

Project description:This study demonstrated the role of the glycolytic enzyme alpha-enolase (ENO1) on glycolysis and stemness in gastric cancer (GC). High ENO1 expression was associated with poor prognosis and promoted malignant phenotypes and stem-like characteristics in GC. Mechanistically, ENO1 directly stimulated lactate and ATP production by regulating glycolysis, affecting lactate homeostasis and intracellular ATP pools, and co-regulating the AMPK/mTOR and PI3K/AKT signaling pathways. This ultimately drove GC stemness, epithelial-mesenchymal transition (EMT)-related markers, self-renewal, migration, and invasion.

2025-09-27 | GSE307717 | GEO

Identification of immediate early transcriptional targets of ephrin-B1 forward signaling

Project description:The goal of this study was to identify immediate early transcriptional targets of ephrin-B1 forward signaling that are relevant to palatogenesis. The Ephs compose a family of receptor tyrosine kinase signaling molecules that can be activated by their cognate ligands, the ephrins. Despite the importance of Eph/ephrin signaling in a wide variety of developmental and cell biological processes, a potential downstream transcriptional response has not been explored. To understand the role of ephrin-B1 signaling in palatogenesis, we examined transcriptional response to ephrin-B1 in a primary mouse embryonic palatal shelf cell culture system. We find an immediate early signature of gene expression that reflects the activation of Erk/MAPK signaling by ephrin-B1 signaling in the palatal shelves. Induction of primary palate cells with 2 ug/ml of pre-clustered ephrin-B1 for one hour. Uninduced primary palate cells are the control. Four replicates each.

2010-09-20 | E-GEOD-23539 | biostudies-arrayexpress

Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4

Project description:In this work, we compared the expression profiles of Anti-MAGE-A4- transduced T-cells with Anti-MAGE-A4- transduced T-cells co-cultured with SK-Mel-37.

2023-07-31 | GSE238191 | GEO

Knockdown of IGFBP7 decreases FGF2 expression in GC.

Project description:Our previous study reported that IGFBP7 plays a role in maintaining mRNA stability of oncogenic lncRNA UBE2CP3 by RNA-RNA interaction. Clinical cohort studies had implied an oncogenic role of IGFBP7 in GC. However, the molecular mechanism of IGFBP7 in driving gastric cancer (GC) progression remains unknown. In this study, clinical analysis based on two independent cohort showed that IGFBP7 was positively associated with poor prognosis and macrophage infiltration in GC. Loss-of-function studies confirmed the oncogenic properties of IGFBP7 in regulating GC cell proliferation and invasion. Mechanismly, IGFBP7 was induced by epithelial-to-mesenchymal transition (EMT) signaling, since its expression was increased by TGF-beta treatment and reduced by overexpression of OVOL2 in GC. RNA sequencing, qRT-PCR, ELISA assay showed that IGFBP7 positively regulating FGF2 expression and secretion. Transcriptome analysis revealed that FGFR1 was downregulated in M1 macrophages but upregulated in M2 macrophages. Exogenous recombinant IGFBP7 protein in macrophages and GC cells further identified that IGFBP7 promotes macrophage polarization towards to a M2/TAM phenotype via FGF2/FGFR1/PI3K/AKT axis. Our finding highlights that IGFBP7 promotes GC by enhancing TAM infiltration through FGF2/FGFR1/PI3K/AKT axis.

2022-07-08 | GSE207373 | GEO

Trancriptome sequencing of BGC823 with or without ZBTB7A knockdown

Project description:Tumor budding (TB), clusters of less than 5 cells dissociated from the tumor mass, is reported to predict nodal involvement and recurrence in multiple human cancers including gastric carcinoma (GC). However, it is not clear how TB forms. In this study, we determined the expression pattern of GAGE12I, CTNND1, Kif26B, CREB1 and ZBTB7A in human GC samples by IHC attempting to find any TB-related markers. The results showed that TB could predict lymph node metastasis and is negatively associated with the overall survival of GC patients. The expression of ZBTB7A in the tumor margin (invasive front), rather than the other four markers, was much higher than that inside the tumor and was positively correlated with TB score. Moreover, patients with higher marginal ZBTB7A expression had poorer prognosis. ZBTB7A could enhance the migration and invasion capabilities of GC cells in vitro. Mechanically, ZBTB7A might activate EGFR-MAPK-ERK and PI3K-AKT-mTOR pathway, which resulted in epithelial-mesenchymal transition (EMT) to induce the formation of TB. Thus, we concluded that higher ZBTB7A expression in the tumor margin may contribute to the dissociation of tumor cells from the tumor mass to form TB by initiating EMT via EGFR-MEK-ERK and PI3K-AKT-mTOR pathway.

2020-12-31 | GSE147199 | GEO

Paenibacillus sp. A4 strain:A4

Project description:Paenibacillus sp. A4 strain:A4 Genome sequencing

| PRJNA360477 | ENA

Identification of immediate early transcriptional targets of ephrin-B1 forward signaling

2010-09-21 | GSE23539 | GEO

WIPF1 promotes gastric cancer progression by regulating PI3K/Akt signaling in a myocardin-dependent manner

Project description:Wiskott–Aldrich syndrome protein-interacting protein family member 1 (WIPF1) is associated with malignant tumor progression. However, molecular links between WIPF1 and gastric cancer (GC) growth and metastasis remain elusive. WIPF1 was detected in GC tissues and cells in cellular and animal models. The molecular regulatory mechanisms of WIPF1 in GC were explored. WIPF1 was overexpressed in GC tissues and cells and high expression of WIPF1 was an independent risk factor for a poor prognosis in patients with GC. In this study, it was demonstrated that WIPF1 increases the proliferation and migration of GC cells in vitro and promotes GC growth and metastasis in vivo by activating PI3K/AKT signaling. Moreover, bioinformatics analysis and subsequent experiments confirmed that myocardin (MYOCD) transactivated WIPF1 expression. Additionally, WIPF1 is necessary for MYOCD to promote the malignant phenotype of GC cells by activating the PI3K/AKT signaling pathway, suggesting that the MYOCD/WIPF1/PI3K/AKT axis may contribute to the onset and development of GC

2023-10-05 | PXD045944 |

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data